Clinical Trial Update: An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating BMS-986205 with nivolumab, with or without chemotherapy, versus chemotherapy in previously untreated stage IV or recurrent non-small …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BMS-986205 (BMS-986205)
• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Lung Cancer, Non-Small Cell Lung Cancer | Phase 3 | Status: WITHDRAWN